Sean Wahlquist1, Scott Nelson2, Phillip Glivar2. 1. Loma Linda University Children's Hospital, 11234 Anderson Street, Loma Linda, CA 92354, USA. Electronic address: swahlquist@llu.edu. 2. Loma Linda University Children's Hospital, 11234 Anderson Street, Loma Linda, CA 92354, USA.
Abstract
STUDY DESIGN: Retrospective cohort. OBJECTIVE: Determine the effect of the ultrasonic bone scalpel (UBS) on intraoperative blood loss and surgical time. SUMMARY OF BACKGROUND DATA: The UBS has shown beneficial effects in limiting blood loss in spinal surgery, but no study has examined its effect in patients with neuromuscular scoliosis. METHODS: Clinical records were reviewed for patients aged 9-18 who underwent posterior spinal fusion surgery of five or more levels for scoliosis correction by the senior author from April 2013 until October 2016. Exclusion criteria included: vertebral column resections, previous spinal surgery, cell saver usage, cases complicated by signal loss on monitoring, and incomplete medical records. A total of 84 patients met the criteria and were included in data analysis. The UBS was routinely used for performing osteotomies and facetectomies for all cases operated after March 2015. These cases were compared to a control group who underwent surgery prior to this date in which the UBS was not used. The experimental and control groups were further divided into adolescent idiopathic (AIS) and neuromuscular (NMS) subgroups. RESULTS: EBL in AIS patients decreased from 1,211 mL in the control group to 771 mL in the UBS group for an average total reduction of 440 mL (95% CI 106, 774, p = .01). In NMS patients, EBL fell from 2,171 mL in controls to 1228 mL in the study group for an average total reduction of 943 mL (95% CI 288, 1598, p < .01). On controlling for weight and number of levels fused, blood loss decreased 26.2% in AIS patients and 46.2% in NMS patients. CONCLUSIONS: The ultrasonic bone scalpel is effective in reducing blood loss in AIS and NMS deformity correction surgery. Surgical time is not adversely affected by its use. LEVEL OF EVIDENCE: Level II, cohort study.
STUDY DESIGN: Retrospective cohort. OBJECTIVE: Determine the effect of the ultrasonic bone scalpel (UBS) on intraoperative blood loss and surgical time. SUMMARY OF BACKGROUND DATA: The UBS has shown beneficial effects in limiting blood loss in spinal surgery, but no study has examined its effect in patients with neuromuscular scoliosis. METHODS: Clinical records were reviewed for patients aged 9-18 who underwent posterior spinal fusion surgery of five or more levels for scoliosis correction by the senior author from April 2013 until October 2016. Exclusion criteria included: vertebral column resections, previous spinal surgery, cell saver usage, cases complicated by signal loss on monitoring, and incomplete medical records. A total of 84 patients met the criteria and were included in data analysis. The UBS was routinely used for performing osteotomies and facetectomies for all cases operated after March 2015. These cases were compared to a control group who underwent surgery prior to this date in which the UBS was not used. The experimental and control groups were further divided into adolescent idiopathic (AIS) and neuromuscular (NMS) subgroups. RESULTS: EBL in AISpatients decreased from 1,211 mL in the control group to 771 mL in the UBS group for an average total reduction of 440 mL (95% CI 106, 774, p = .01). In NMSpatients, EBL fell from 2,171 mL in controls to 1228 mL in the study group for an average total reduction of 943 mL (95% CI 288, 1598, p < .01). On controlling for weight and number of levels fused, blood loss decreased 26.2% in AISpatients and 46.2% in NMSpatients. CONCLUSIONS: The ultrasonic bone scalpel is effective in reducing blood loss in AIS and NMS deformity correction surgery. Surgical time is not adversely affected by its use. LEVEL OF EVIDENCE: Level II, cohort study.
Authors: Alexander Mihas; Subaraman Ramchandran; Sebastian Rivera; Ali Mansour; Jahangir Asghar; Harry Shufflebarger; Stephen George Journal: BMC Musculoskelet Disord Date: 2021-02-19 Impact factor: 2.362